195 related articles for article (PubMed ID: 9539564)
1. The clinical implications of hydronephrosis and the level of ureteral obstruction in stage IIIB cervical cancer.
Chao KS; Leung WM; Grigsby PW; Mutch DG; Herzog T; Perez CA
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1095-100. PubMed ID: 9539564
[TBL] [Abstract][Full Text] [Related]
2. Impact of hydronephrosis on outcome of stage IIIB cervical cancer patients with disease limited to the pelvis, treated with radiation and concurrent chemotherapy: a Gynecologic Oncology Group study.
Rose PG; Ali S; Whitney CW; Lanciano R; Stehman FB
Gynecol Oncol; 2010 May; 117(2):270-5. PubMed ID: 20181381
[TBL] [Abstract][Full Text] [Related]
3. Figo IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy.
Logsdon MD; Eifel PJ
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):763-75. PubMed ID: 10098431
[TBL] [Abstract][Full Text] [Related]
4. Renal sonography in the diagnosis of renal obstruction or hydronephrosis in patients with cervical cancer.
Vanderpuye V
J Clin Ultrasound; 2002 Sep; 30(7):424-7. PubMed ID: 12210460
[TBL] [Abstract][Full Text] [Related]
5. Hydronephrosis in patients with cervical cancer: An improved stent-change therapy for ureteral obstruction Stent-change for ureteral obstruction in cervical cancer.
Li J; Cao H; Peng K; Chen R; Sun X
Eur J Obstet Gynecol Reprod Biol; 2023 Apr; 283():49-53. PubMed ID: 36773470
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in advanced stage squamous cell cancer of the cervix.
Hopkins MP; Morley GW
Cancer; 1993 Oct; 72(8):2389-93. PubMed ID: 8402454
[TBL] [Abstract][Full Text] [Related]
7. Pelvic radiotherapy in patients with hydronephrosis in stage IIIB cancer of the cervix: renal effects and the optimal timing for urinary diversion?
Horan G; McArdle O; Martin J; Collins CD; Faul C
Gynecol Oncol; 2006 Jun; 101(3):441-4. PubMed ID: 16337996
[TBL] [Abstract][Full Text] [Related]
8. Survival Outcome of Urinary Diversion in Advanced Cervical Cancer Patients with Hydronephrosis.
Dhani FK; Daryanto B; Seputra KP
Asian Pac J Cancer Prev; 2023 Aug; 24(8):2641-2646. PubMed ID: 37642049
[TBL] [Abstract][Full Text] [Related]
9. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience.
Petereit DG; Sarkaria JN; Potter DM; Schink JC
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1267-74. PubMed ID: 10613322
[TBL] [Abstract][Full Text] [Related]
10. Postradiation ureteral obstruction: a reappraisal.
Muram D; Oxorn H; Curry RH; Drouin P; Walters JH
Am J Obstet Gynecol; 1981 Feb; 139(3):289-93. PubMed ID: 7468696
[TBL] [Abstract][Full Text] [Related]
11. Laparoscopic surgical staging in cervical cancer--preliminary experience among Chinese.
Chu KK; Chang SD; Chen FP; Soong YK
Gynecol Oncol; 1997 Jan; 64(1):49-53. PubMed ID: 8995546
[TBL] [Abstract][Full Text] [Related]
12. Unilateral hydronephrosis resulting from intraluminal obstruction of the ureter by adenosquamous endometrioid carcinoma arising from disseminated endometriosis.
Jimenez RE; Tiguert R; Hurley P; An T; Grignon DJ; Lawrence D; Triest J
Urology; 2000 Aug; 56(2):331. PubMed ID: 10925117
[TBL] [Abstract][Full Text] [Related]
13. Medical treatment of ureteral obstruction associated with ovarian remnants and/or endometriosis: report of three cases and review of the literature.
Vilos GA; Marks-Adams JL; Vilos AG; Oraif A; Abu-Rafea B; Casper RF
J Minim Invasive Gynecol; 2015; 22(3):462-8. PubMed ID: 25533869
[TBL] [Abstract][Full Text] [Related]
14. Mature results of a pilot study of pelvic radiotherapy with concurrent continuous infusion intra-arterial 5-FU for stage IIIB-IVA squamous cell carcinoma of the cervix.
Chaney AW; Eifel PJ; Logsdon MD; Morris M; Wharton JT
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):113-8. PubMed ID: 10477014
[TBL] [Abstract][Full Text] [Related]
15. Patterns of spread in node-positive cervical cancer: the relationship between local control and distant metastases.
Stock RG; Chen AS; Karasek K
Cancer J Sci Am; 1996; 2(5):256-62. PubMed ID: 9166542
[TBL] [Abstract][Full Text] [Related]
16. [Etiopathogenesis of so-called congenital hydronephrosis].
Puigvert A; Ruano D
J Urol Nephrol (Paris); 1979; 85(1-2):1-12. PubMed ID: 439196
[TBL] [Abstract][Full Text] [Related]
17. Hydronephrosis as a prognostic indicator of survival in advanced cervix cancer.
Pradhan TS; Duan H; Katsoulakis E; Salame G; Lee YC; Abulafia O
Int J Gynecol Cancer; 2011 Aug; 21(6):1091-6. PubMed ID: 21738045
[TBL] [Abstract][Full Text] [Related]
18. Effect of hydronephrosis on survival in advanced stage cervical cancer.
Goklu MR; Seckin KD; Togrul C; Goklu Y; Tahaoglu AE; Oz M; Ertas IE
Asian Pac J Cancer Prev; 2015; 16(10):4219-22. PubMed ID: 26028076
[TBL] [Abstract][Full Text] [Related]
19. [Wall stents for treatment of malignant ureteral obstruction].
Lugmayr H; Pauer W
Aktuelle Radiol; 1994 May; 4(3):146-8. PubMed ID: 7519450
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of cervical size and pelvic lymph node status assessed by computed tomography for patients with uterine cervical cancer treated by radical radiation therapy.
Toita T; Nakano M; Higashi M; Sakumoto K; Kanazawa K
Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):843-9. PubMed ID: 7591892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
